The question the researchers set out to address is deceptively simple: do different chemotherapy regimens leave different signatures on brain function? This matters because so-called chemotherapy-related cognitive impairment, often described by patients as brain fog, has mostly been studied as a single phenomenon, as if all cytotoxic drugs affected the brain in the same way. If different regimens produce measurably different network alterations, that could eventually help clinicians predict which patients are most at risk and open the door to regimen-specific protective strategies. The authors are careful, however, to frame their results as regimen-associated associations rather than proof of direct causation, because the two patient groups differed not only in their drugs but also in their cancer types, metastatic patterns, and specific treatment combinations.

To probe the brain’s wiring, the team enrolled 43 colorectal cancer patients who had completed two to three months of fluorouracil-based chemotherapy and 54 non-small cell lung cancer patients who had received two to three months of carboplatin-based chemotherapy. At the end of treatment, each participant underwent resting-state functional MRI, a technique that records spontaneous, low-frequency fluctuations in blood-oxygen signals while the subject simply lies still in the scanner. Because these fluctuations are synchronized across regions that work together, the timing patterns can be used to reconstruct the brain’s functional connectome, a map of which areas are talking to which.

The first analytical approach was graph theory, a branch of mathematics that treats the brain as a network of nodes and edges. Each region of a standardized brain parcellation becomes a node, and the statistical correlation between its activity and that of other regions defines the edges. From this network the researchers computed nodal metrics such as degree, a measure of how many strong connections a region maintains, and global efficiency, which captures how easily that region can exchange information with the rest of the network. When the two patient groups were compared, one result stood out after correction for multiple comparisons, the statistical safeguard that guards against false positives when thousands of brain regions are tested simultaneously.

That robust finding centered on the left precuneus, a hub tucked into the medial parietal cortex that plays a central role in self-referential thought, memory retrieval, and consciousness itself. Patients treated with carboplatin-based chemotherapy showed decreased nodal degree and decreased nodal global efficiency in the left precuneus compared with patients who had received fluorouracil-based treatment. In plain terms, this key integrative hub appeared less connected and less efficient at relaying information in the carboplatin group. Because this result survived multiple comparison correction, the authors consider it the most reliable signal in the study, and it points to carboplatin-based regimens being associated with more pronounced topological alterations in this region.

The second line of analysis used group independent component analysis, a data-driven method that decomposes whole-brain signals into spatially coherent networks without imposing a prior template. This procedure identified the canonical resting-state networks familiar to systems neuroscientists, including the default mode network in its dorsal and ventral subdivisions, the salience network, the left and right executive control networks, the sensorimotor network, the language network, the auditory network, and the primary visual network. The researchers then examined how strongly these networks communicated with one another, both in a static sense, averaged across the entire scan, and dynamically, by tracking how connectivity patterns shift from moment to moment across short sliding windows.

The static connectivity comparisons revealed a pattern of reduced communication in the colorectal cancer group. Patients who had received fluorouracil-based chemotherapy showed decreased connectivity within the right cuneus, part of the precuneus network, and reduced inter-network connectivity between the dorsal default mode network and the salience network, between the dorsal default mode network and the language network, between the ventral default mode network and the primary visual network, and between the sensorimotor network and the primary visual network. The default mode network, which is active when the mind wanders and reflects, and the salience network, which decides which stimuli deserve attention, are both repeatedly implicated in cognitive complaints after cancer treatment, so a weakening of the bridge between them is intriguing.

The dynamic analysis added a temporal dimension that static measures cannot capture. By clustering the sequence of connectivity states across time, the team identified four recurring brain states, each representing a distinct temporary configuration of network communication. Patients in the fluorouracil group spent less time in one particular configuration, showing decreased mean dwell time and a reduced fraction of windows in State 2. Within that state, the colorectal cancer patients displayed increased dynamic connectivity between the salience network and the right executive control network, and between the sensorimotor network and the language and primary visual networks, alongside decreased dynamic connectivity involving the left executive control network with the sensorimotor, auditory, and visual networks, and the right executive control network with the sensorimotor network. These shifting patterns suggest that the two regimens are associated not just with different average levels of connectivity but with different styles of moment-to-moment network reconfiguration.

The authors are explicit about the hierarchy of confidence in their results. The graph theory findings, having survived multiple comparison correction, are described as more robust, whereas the static and dynamic functional network connectivity results are presented as exploratory and in need of independent validation. They also stress the limits imposed by clinical reality: the study compared patients with different cancers, different metastatic patterns, and multiple regimens within each group, so it cannot isolate the pharmacological effect of carboplatin versus fluorouracil from the effects of the underlying disease. What the study does establish is that the two groups, defined by their treatment regimens, show measurably different brain network architectures at the end of therapy, a result consistent with the idea that chemotherapy-related brain changes are not uniform across drug classes.

For patients and clinicians, the significance of this work lies in its direction rather than its immediate application. The precuneus alterations associated with carboplatin-based treatment and the widespread default mode, salience, and executive network changes associated with fluorouracil-based treatment provide concrete, imaging-based targets that future longitudinal studies can follow from before chemotherapy through recovery. If larger, better-controlled cohorts confirm that specific regimens produce specific network signatures, resting-state MRI could eventually become a practical surveillance tool for the brain during cancer care, helping to identify which survivors need cognitive support and guiding the design of regimens that treat the tumor while sparing the mind. The study, approved by the Ethical Commission of Jiangsu Cancer Hospital and conducted under the Declaration of Helsinki, is open access, allowing researchers worldwide to build on its graph-theoretic and independent component analysis framework.

Subject of Research: Differential effects of fluorouracil-based versus carboplatin-based chemotherapy on resting-state functional brain networks in colorectal and lung cancer patients

Article Title: Distinct functional brain network alterations associated with 5-fluorouracil- and carboplatin-based chemotherapy regimens in CRC and NSCLC patients: a combined graph theory and group ICA study based on rs-fMRI

Article References: Distinct functional brain network alterations associated with 5-fluorouracil- and carboplatin-based chemotherapy regimens in CRC and NSCLC patients: a combined graph theory and group ICA study based on rs-fMRI. (n.d.). https://doi.org/10.1186/s12880-026-02823-0

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02823-0

Keywords: chemotherapy, cognitive impairment, resting-state fMRI, graph theory, independent component analysis, precuneus, default mode network, salience network, colorectal cancer, non-small cell lung cancer, 5-fluorouracil, carboplatin

The research, led by Chonggang Tong and Yuwei Su of the Beijing University of Posts and Telecommunications, together with colleagues, focused on homotopic functional connectivity, or HFC, the degree to which mirror-image regions in the left and right hemispheres synchronize their activity. This direct communication between corresponding brain areas is fundamental to integrating information across the two halves of the brain, supporting everything from motor coordination to language and attention. While previous studies had hinted at HFC alterations in Alzheimer’s disease, most were confined to small cohorts and simple statistical comparisons, producing inconsistent and often contradictory findings.

To overcome these limitations, the team assembled a dataset of 799 subjects drawn from seven different imaging sites, comprising 289 individuals with Alzheimer’s disease, 253 with mild cognitive impairment, and 257 cognitively normal controls. This scale matters. Multicenter designs introduce considerable variability in scanner hardware, acquisition protocols and participant demographics, but they also provide the statistical power and generalizability that small single-site studies lack. By pooling results across sites using random-effects meta-analysis, the researchers could distinguish robust disease effects from site-specific noise.

The team’s methodological pipeline began with functional magnetic resonance imaging, measuring blood-oxygen-level-dependent signals while participants rested in the scanner. From these data, they computed HFC for every participant, quantifying the temporal correlation between homotopic pairs of brain regions. They also derived a suite of structural asymmetry measures from structural MRI, including gray matter volume, fractal dimension, cortical thickness, sulcal depth and gyral index, allowing them to ask whether functional changes in cross-hemisphere communication track with structural differences between hemispheres.

For each imaging site, the researchers ran linear regression models with diagnosis as the main effect of interest and age and sex as covariates, then combined the resulting effect sizes across all seven sites through meta-analysis. The pattern that emerged was unambiguous and hierarchically organized. In posterior and subcortical regions, HFC was systematically reduced in Alzheimer’s patients. The reduction was particularly pronounced in the right hippocampus, with a Cohen’s d effect size of −0.541, and in the medial amygdala, with a Cohen’s d of −0.330, both surviving correction for false discovery rate. These regions, which include structures central to memory processing, showed the earliest and strongest erosion of interhemispheric synchronization.

In contrast, a focal and unexpected increase in HFC appeared in the prefrontal cortex, specifically in the medial anterior prefrontal area A9m, where the effect size reached a Cohen’s d of 0.391. This anterior-posterior gradient, with posterior and subcortical connectivity collapsing while certain prefrontal connections are strengthened, suggests that Alzheimer’s disease does not simply degrade cross-hemisphere communication uniformly. Instead, the brain appears to undergo a hierarchical reconfiguration, possibly reflecting compensatory mechanisms in frontal regions that attempt to offset deteriorating posterior networks, or perhaps a pathological redistribution of neural resources as the disease progresses.

Beyond mapping this pattern, the team tested whether HFC could serve as a practical diagnostic biomarker. They trained support vector machines, a widely used machine learning algorithm, to classify individuals as having Alzheimer’s disease or not, based on their HFC profiles. Crucially, they employed leave-one-site-out cross-validation, training the classifier on data from six sites and testing it on the held-out seventh, cycling through all seven configurations. This rigorous scheme ensures that the reported performance reflects genuine disease signals rather than scanner-specific artifacts. The classifier achieved a mean accuracy of 0.745 across sites, with an area under the curve of 0.815 and an F1 score of 0.774.

The researchers then asked whether adding structural asymmetry measures would sharpen the model’s diagnostic power. It did. Integrating gray matter volume, cortical thickness and the other structural metrics with HFC improved classification accuracy by up to 0.129, indicating that functional and structural signatures of hemispheric asymmetry carry complementary information about the disease. In a parallel analysis, support vector regression was applied to predict individual Mini-Mental State Examination scores, the standard bedside measure of cognitive status, from the same imaging features, probing whether the biomarker could capture disease severity rather than just diagnostic category.

The implications extend beyond the laboratory. Current biomarkers for Alzheimer’s disease, including cerebrospinal fluid assays and PET amyloid imaging, are expensive and invasive, while structural MRI alone captures late-stage neurodegeneration. A resting-state fMRI measure of homotopic connectivity, requiring no contrast agent and only a few minutes of scanning, could offer a cost-effective complement for early detection and for monitoring response to the growing arsenal of disease-modifying therapies. The finding that mild cognitive impairment sits between controls and Alzheimer’s disease in this hierarchy of connectivity changes further suggests HFC may track disease progression.

The study’s authors, whose work was supported by China’s National Science and Technology Major Project and the National Natural Science Foundation of China, caution that HFC is not yet a standalone diagnostic tool. Effect sizes at the individual level remain moderate, and clinical deployment will require validation in independent cohorts and harmonization of acquisition protocols. Nevertheless, the demonstration that interhemispheric dialogue is hierarchically reconfigured in Alzheimer’s disease, reproducibly across seven sites and nearly eight hundred brains, deepens understanding of the neural mechanisms underlying the disease and provides a concrete, measurable target for future therapeutic investigations and individualized assessment.

Subject of Research: Multicenter analysis of homotopic functional connectivity changes between brain hemispheres in Alzheimer's disease

Article Title: Hierarchical reconfiguration of interhemispheric dialogue in Alzheimer’s disease: a multicenter analysis

Article References: Tong, C., Su, Y., Zhang, W., Hu, P., Zhao, C., Liu, Y., & Zhong, S. (2026). Hierarchical reconfiguration of interhemispheric dialogue in Alzheimer’s disease: a multicenter analysis. BMC Medicine. https://doi.org/10.1186/s12916-026-05234-8

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05234-8

Keywords: Alzheimer's disease, homotopic functional connectivity, interhemispheric communication, neuroimaging biomarker, resting-state fMRI, mild cognitive impairment, support vector machine, multicenter study, brain asymmetry, hippocampus, prefrontal cortex, machine learning

A new study published in the journal Neuroinformatics tackles this reproducibility crisis head on. Hossein Haghighat, of the Department of Computer Engineering at Kashmar Higher Education Institute in Iran, has built a neuroinformatics framework designed to systematically compare how different functional connectivity measures perform under exactly the conditions where machine learning is most fragile: small samples. Rather than chasing another incremental gain in diagnostic accuracy, the work asks a more fundamental question, namely which mathematical descriptions of brain communication actually carry reliable information about autism, and whether the answer changes across human development.

The technical pipeline at the heart of the framework begins with group independent component analysis, a data-driven decomposition technique that separates the four-dimensional fMRI signal into spatial networks reflecting coherent, resting-state activity. Once these group-level networks are identified, dual regression is applied to extract subject-specific time series for each network in every participant. This two-step strategy, well established in the neuroimaging literature, allows each individual’s connectivity to be expressed relative to a common set of whole-brain networks, from the default mode network to attentional and sensorimotor systems, while still preserving person-level variability.

On top of these network time series, the framework computes five distinct functional connectivity measures, deliberately chosen to span the major families of interaction statistics used in the field. Full correlation captures straightforward linear co-fluctuation between networks. Partial correlation isolates direct linear relationships by statistically removing the influence of all other networks. Bivariate Granger causality introduces directionality, testing whether activity in one network helps predict future activity in another. Coherence moves the analysis into the frequency domain, quantifying synchronized oscillations at specific temporal rhythms. Finally, mutual information, an information-theoretic quantity, captures nonlinear statistical dependencies that linear measures can miss entirely. Together, these metrics cover time-domain and frequency-domain interactions, linear and nonlinear coupling, and directed and undirected relationships.

The study analyzed resting-state data drawn from the Autism Brain Imaging Data Exchange, or ABIDE, an openly shared multinational repository that aggregates scans from many imaging sites. Crucially, the analyses were stratified across three developmental stages: children, adolescents, and adults. This age-stratified design reflects a growing recognition in autism research that the brain differences associated with the condition are not static. Large-scale neural networks continue to mature throughout childhood and adolescence, and previous work by the same author and others has documented age-related patterns of both hypo-connectivity and hyper-connectivity in autism. A connectivity measure that performs well in one age band may fail entirely in another, and pooling ages can mask these developmental dynamics.

The methodological centerpiece of the framework, however, is its insistence on leakage-aware evaluation. In small-sample neuroimaging, datasets contain far more connectivity features, potentially thousands of pairwise relationships, than participants, creating a high-dimensional feature space in which classifiers can trivially overfit. The danger is compounded by a subtle but pervasive error known as data leakage, in which feature selection is performed on the entire dataset before cross-validation begins. When that happens, information from the test samples has already influenced the choice of features, inflating apparent accuracy in a way that is invisible to the researcher but catastrophic for real-world generalization. Reviews of prediction practices in psychiatry and neuroimaging have repeatedly flagged this trap as a leading cause of over-optimistic results.

Haghighat’s framework closes this loophole by performing feature selection strictly within the training folds of a leave-one-out cross-validation scheme. In every iteration of the cross-validation loop, one participant is held out, features are ranked and selected using only the remaining participants, a classifier is trained on that reduced feature set, and only then is the held-out participant classified. Multiple machine learning classifiers were employed as standardized evaluation tools, allowing the comparison to focus on the relative merits of the connectivity measures themselves rather than the quirks of any single algorithm. This disciplined protocol produces performance estimates that, while perhaps less spectacular than leaked estimates, are far more honest reflections of the information genuinely contained in each connectivity metric.

The results reveal a striking developmental structure. Linear connectivity measures, particularly full and partial correlation, showed the most stable behavior in childhood, suggesting that in young brains the dominant autism-related signal is carried by straightforward linear co-activation patterns among large-scale networks. In adolescence, by contrast, nonlinear information-theoretic measures, chiefly mutual information, proved the most informative, hinting that the reorganization of neural circuits during teenage years may generate interaction patterns that linear statistics fail to capture. In adulthood, frequency-domain measures demonstrated stronger performance, consistent with the idea that rhythmic synchronization properties of adult networks encode diagnostic information that time-domain correlation obscures. No single measure dominated across the lifespan, which is precisely the point: the optimal choice of connectivity metric depends on the developmental stage of the sample being studied.

These findings carry practical consequences for anyone building diagnostic or biomarker tools from resting-state fMRI. The autism neuroimaging community has long wrestled with the heterogeneity of the condition itself, the variability introduced by multi-site data collection, and the statistical fragility of small clinical samples. Previous multisite classification efforts have shown that reported accuracies depend heavily on sample composition, and comprehensive reviews of connectivity findings in autism have described a confusing mix of over- and under-connectivity results that defy simple summary. By benchmarking measures within a single, leakage-controlled framework and across age bands, the new study offers researchers a practical reference for selecting connectivity metrics appropriate to their populations, and a template for the kind of rigorous cross-validation that reviewers and journals are increasingly demanding.

Perhaps most importantly, the work reframes what a successful neuroimaging machine learning study should look like. Instead of presenting yet another classifier with an eye-catching accuracy figure, it emphasizes comparative methodological evaluation, transparency about overfitting risks, and developmental specificity. As the field moves toward clinical translation, where connectivity-based measures might one day support diagnosis or subtype identification, such methodological hygiene is not optional. Frameworks like this one provide the benchmarking infrastructure needed to separate genuine neural signatures of autism from statistical artifacts, and they suggest that the path to reliable neuroimaging biomarkers runs through careful, age-aware, leakage-free evaluation rather than through bigger accuracy numbers alone. The study received no external funding, and its underlying data remain publicly available through the ABIDE initiative, lowering the barrier for other teams to adopt and extend the approach.

Subject of Research: Evaluation of functional connectivity metrics for machine learning analysis of resting-state fMRI in age-stratified autism spectrum disorder research

Article Title: A Neuroinformatics Framework for Evaluating Functional Connectivity Metrics in Small-Sample Resting-State fMRI: An Age-Stratified Autism Study

Article References: Haghighat, H. (2026). A Neuroinformatics Framework for Evaluating Functional Connectivity Metrics in Small-Sample Resting-State fMRI: An Age-Stratified Autism Study. Neuroinformatics, 24(3), Article 60. https://doi.org/10.1007/s12021-026-09816-y

Image Credits: AI Generated

DOI: 10.1007/s12021-026-09816-y

Keywords: autism spectrum disorder, functional connectivity, resting-state fMRI, machine learning, independent component analysis, dual regression, Granger causality, mutual information, coherence, cross-validation, data leakage, neuroinformatics

The research drew on two of the largest biomarker studies in depression research: EMBARC, the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care trial conducted in the United States, and CAN-BIND-1, the Canadian Biomarker Integration Network in Depression. Together, the cohorts included 386 patients aged 18 to 65, with 257 women and 129 men. Participants were randomly assigned to receive the selective serotonin reuptake inhibitors sertraline or escitalopram, or a placebo, with 123 patients on sertraline, 138 on escitalopram and 125 on placebo. Crucially, each patient underwent resting-state functional MRI scans both before treatment and again after one to two weeks of medication, allowing the researchers to compute how thousands of pairwise connectivity relationships between brain regions changed as treatment began.

Functional connectivity, measured as the temporal correlation of spontaneous blood-oxygen-level-dependent signal between brain areas, provides a window into the brain’s intrinsic organization without requiring patients to perform any task. The team faced a familiar obstacle in this kind of data: the signal-to-noise ratio of individual connectivity edges is low, and naive machine learning models tend to latch onto features that do not replicate. To address this, the researchers developed an innovative analytical strategy combining predictive and contrastive machine learning frameworks, constrained to connectivity changes with sufficient reliability. The contrastive component allowed them to statistically disentangle effects that are common to all treated patients from effects specific to drug or to placebo, a decomposition that has rarely been attempted at this scale.

The first major finding was a universal signature. Regardless of whether patients received sertraline, escitalopram or placebo, and regardless of whether their symptoms ultimately improved, nearly all medicated patients showed increased connectivity within a system linking visual cortex, the precuneus and the thalamus. The precuneus, a hub of the brain’s default mode network implicated in self-referential thought and memory, and the thalamus, the brain’s central relay station, are both known to interact with visual processing regions. Earlier work has shown that placebo treatment can alter primary visual cortex activity and connectivity, and this new result places those observations within a much larger and more systematic framework. The consistency of this visual-precuneus-thalamus change across two independent cohorts suggests it reflects a generalizable response to entering pharmacological treatment for depression, not a drug-specific mechanism.

By contrast, the neural correlates of placebo-related symptom improvement were centered elsewhere. The study found that striatal and attention networks mediated the placebo-driven reduction in depressive symptoms. The striatum, a subcortical structure central to reward processing and motivational learning, has repeatedly been implicated in placebo phenomena, including a well-known finding that reward-related ventral striatal activity distinguishes sertraline responders from placebo responders. The involvement of attention networks aligns with the psychological literature on expectation, which holds that placebo effects arise when anticipation and attention reorient the brain’s evaluative machinery. In practical terms, patients whose early connectivity shifts in these networks were pronounced were the ones whose symptoms improved most from expectation and context, independent of any pharmacological action.

The true drug effects were narrower and more selective than many researchers expected. Connectivity changes specific to sertraline and escitalopram converged on the amygdala, the midcingulate cortex, the orbitofrontal cortex and the cerebellum. These are regions with wellestablished roles in emotional regulation and depression: the amygdala generates threat and salience responses, the orbitofrontal cortex evaluates reward and punishment, the midcingulate cortex integrates motivation and control, and the cerebellum, long dismissed as purely motor, is increasingly recognized as a participant in cognitive and affective circuitry, with altered cerebellar-cerebral connectivity reliably distinguishing patients with depression. Notably, these drug-specific changes appeared in only a subset of the patients actually taking antidepressants. Pharmacological treatment, in other words, leaves a detectable early neural fingerprint in some brains but not in others, a neural reflection of the heterogeneity that has always frustrated clinicians.

The most clinically consequential finding emerged from that heterogeneity. When patients on sertraline did not show the drug-specific amygdala, midcingulate, orbitofrontal or cerebellar connectivity changes, their responses could be predicted using a model trained on placebo response signatures. This implies that a substantial share of what looks like antidepressant response in the clinic may actually be placebo response occurring in medicated patients. Given that systematic reviews of antidepressant trials have long documented substantial and growing placebo response rates, this study provides a mechanistic account of why: expectation engages striatal and attentional circuitry, and patients who are predisposed to engage that circuitry will improve whether or not the drug’s molecular mechanisms take hold in their emotional-regulation circuits.

Methodologically, the study’s strength lies in its cross-cohort validation. Patterns identified in one cohort were tested in the other, and the universal visual-precuneus-thalamus changes, the placebo mediators and the drug-specific effects all replicated across the EMBARC and CAN-BIND-1 datasets, which used different scanners, sites and clinical protocols. The analysis pipeline itself was rigorous, employing established preprocessing tools including fMRIPrep, boundary-based registration, ICA-based motion artifact removal and standard strategies to control the spurious correlations introduced by subject head motion. The predictive models were evaluated with cross-validated Pearson correlations between predicted and observed symptom change, and hyperparameters governing sparsity were tuned to avoid overfitting. The code was released publicly through Code Ocean, and the EMBARC data are available through the National Institute of Mental Health Data Archive, inviting independent scrutiny.

The implications for patient care are considerable. Today, deciding whether an antidepressant is working typically requires six to eight weeks of observation, and roughly half of patients discontinue treatment early, often because of side effects before any benefit arrives. If early connectivity changes measured after one week could be incorporated into an interactive treatment optimization framework, clinicians could potentially distinguish, within days, patients whose brains are responding to the drug’s pharmacology from patients whose trajectory depends on placebo-related circuitry, who might instead benefit from psychotherapy, neuromodulation or placebo-enhanced care strategies. This aligns with a broader movement in psychiatry toward biosignature-guided treatment, including prior work from overlapping research groups demonstrating that electroencephalographic signatures and structure-function covariation patterns can predict antidepressant response.

Important caveats remain. The study examined only two serotonergic medications over a brief window, and it remains unknown whether the same signatures generalize to other antidepressant classes, to longer treatment durations, or to adolescent and older populations. Resting-state fMRI measures indirect hemodynamic activity rather than neural firing, and even carefully denoised connectivity estimates carry residual uncertainty at the individual level. The authors also note that drug-specific connectivity changes were present in a subset rather than all medicated responders, so the absence of such changes does not guarantee nonresponse. Still, by systematically partitioning early brain changes into universal, placebo-mediated and drug-specific components, the study delivers what the field has lacked: a mechanistic map of how treatment for depression begins in the brain, weeks before the patient reports feeling better. It transforms the placebo from a statistical nuisance into a defined neural process, and it moves precision psychiatry a tangible step closer to the clinic.

Subject of Research: Early treatment-induced changes in brain functional connectivity in major depressive disorder following antidepressant or placebo administration

Article Title: Early brain functional connectivity changes induced by antidepressants and placebo

Article References: Tong, X., Fonzo, G. A., Carlisle, N. B., Xie, H., Berdichevsky, Y., Keller, C. J., Oathes, D. J., Nemeroff, C. B., Lin, F. V., & Zhang, Y. (2026). Early brain functional connectivity changes induced by antidepressants and placebo. Nature Mental Health. https://doi.org/10.1038/s44220-026-00729-y

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00729-y

Keywords: major depressive disorder, functional connectivity, antidepressants, placebo effect, sertraline, escitalopram, machine learning, resting-state fMRI, EMBARC, CAN-BIND, biomarkers, precision psychiatry

The default mode network has occupied a central place in cognitive neuroscience since its discovery in the early 2000s, when positron emission tomography and, later, functional magnetic resonance imaging revealed a set of regions that consistently decrease their activity during demanding external tasks and increase it during quiet rest. This network, anchored in the medial prefrontal cortex, the posterior cingulate cortex, the precuneus, and the inferior parietal lobule, is thought to support autobiographical memory retrieval, envisioning the future, self-referential processing, and mind-wandering. In schizophrenia, decades of imaging work have documented disruptions in this network’s connectivity, which have been linked to disturbances in self-monitoring, hallucination severity, and disorganized thought. What the new study adds is a bridge between this circuitry and one of the most consequential health behaviors in the disorder: smoking.

The researchers approached the question using resting-state functional connectivity analysis, a technique that measures the degree to which spatially distributed brain regions fluctuate together in their blood-oxygen-level-dependent signals while participants lie quietly in the scanner. Synchronized low-frequency fluctuations are interpreted as a signature of functional coupling, even though they do not directly measure anatomical wiring. By parcellating the cortex and extracting connectivity profiles associated with the default mode network, the team was able to quantify how strongly parietal nodes of this circuit communicated with the rest of the network and with other major systems, including the frontoparietal control network and the salience network, which are implicated in cognitive control and in switching between internal and external attention.

Across the study sample, the strength of parietal default mode connectivity emerged as a statistically reliable correlate of tobacco use measures, which for many participants included biologically verified indicators such as cotinine levels, the primary metabolite of nicotine, rather than relying solely on self-report. This methodological point matters enormously. Self-reported smoking in psychiatric populations is notoriously unreliable, shaped by stigma, recall difficulty, and cognitive impairment, and studies that depend on it risk both overestimation and underestimation of true exposure. By anchoring the smoking phenotype in objective biochemical measures where available, the analysis strengthens the claim that the brain-behavior association is genuine rather than an artifact of reporting bias.

Why should a network associated with daydreaming and self-referential thought care about nicotine? One plausible explanation lies in the interplay between the default mode network and dopaminergic signaling. Nicotine acts on nicotinic acetylcholine receptors that modulate dopamine release in the mesolimbic pathway, the reward circuitry that reinforces drug-taking. In psychosis, this dopaminergic system is already dysregulated, with the prevailing neurobiological models of schizophrenia positing aberrant striatal dopamine synthesis and release as a proximate cause of positive symptoms. Nicotine’s ability to transiently normalize aspects of this signaling, or to dampen sensory gating deficits, has long been cited in self-medication accounts. The new findings suggest that individual differences in the intrinsic organization of the default mode network may reflect, or even partly determine, the degree to which nicotine exerts reinforcing and normalizing effects in a given brain.

A complementary interpretation comes from the cognitive domain. The default mode network and the frontoparietal control network are engaged in a dynamic antagonist relationship: when the former is active, the latter is typically suppressed, and effective cognitive performance requires the orchestration of switching between internally and externally directed states. Smoking initiation and maintenance depend on executive functions, including the capacity to inhibit impulses, delay gratification, and weigh long-term health consequences against immediate relief. If parietal default mode connectivity indexes the rigidity of internal focus or the difficulty of disengaging from internally generated thought, then individuals with stronger or atypical coupling may find external, health-protective control processes harder to deploy, making tobacco use more likely to persist. In this framing, connectivity is not a cause of smoking in a simple causal chain but a marker of the neurocognitive soil in which the behavior takes root.

The psychosis context amplifies both the scientific and clinical significance of these results. Roughly three-quarters of people with schizophrenia who smoke do so heavily, and smoking accounts for the majority of the excess mortality observed in the disorder. Yet smokers with psychosis are less likely to receive smoking cessation counseling, less likely to be prescribed pharmacotherapy such as varenicline or bupropion, and more likely to relapse after quitting attempts. If neural measures such as default mode connectivity could stratify patients by the likely neurobiological drivers of their smoking, clinicians might eventually tailor interventions accordingly, deploying more intensive combined behavioral and pharmacological strategies for those whose circuit profiles indicate a strongly entrenched pattern. The present study does not yet support such clinical deployment, but it supplies the kind of mechanistic correlate that personalized approaches require.

As with all resting-state connectivity research, important caveats frame the interpretation. Functional connectivity is correlational; the cross-sectional design of the analysis cannot determine whether atypical parietal connectivity predisposes individuals to smoking, whether chronic nicotine exposure reshapes the network over time, or whether both are downstream of a third factor such as illness severity, medication exposure, or shared genetic risk. Longitudinal designs, within-person repeated imaging, and causal modeling techniques, including studies in animal models where nicotine exposure can be experimentally controlled, will be needed to disentangle these possibilities. Sample heterogeneity, medication effects, and the modest effect sizes typical of brain-wide association studies further caution against overreading any single result. Still, the consistency of the default mode network’s involvement across cognitive, symptomatic, and now behavioral domains in psychosis builds a cumulative case that this circuit is a genuine hub of individual difference in the disorder.

For the broader field, the study exemplifies a trend in psychiatric neuroscience toward connecting large-scale intrinsic brain organization with real-world health behaviors, rather than with abstract laboratory measures alone. Smoking is among the most modifiable risk factors in severe mental illness, and understanding its neural correlates is a step toward interventions that could meaningfully extend lives. The finding that the brain’s daydreaming circuitry carries information about tobacco use in psychosis is a reminder that even the most habitual and seemingly volitional behaviors are embedded in the biology of the disorders themselves, and that dismantling smoking’s grip on this vulnerable population may ultimately require working with, rather than around, the architecture of the psychotic brain.

Subject of Research: Resting-state parietal default mode network functional connectivity and its association with tobacco use in psychotic disorders

Article Title: Parietal default mode network connectivity is associated with tobacco use in psychosis

Article References: Parietal default mode network connectivity is associated with tobacco use in psychosis. (n.d.). https://doi.org/10.1038/s41537-026-00797-0

Image Credits: AI Generated

DOI: 10.1038/s41537-026-00797-0

Keywords: schizophrenia, psychosis, default mode network, tobacco use, nicotine, functional connectivity, resting-state fMRI, neuroimaging, dopamine, smoking cessation, parietal cortex, severe mental illness

Carotid stenosis refers to the narrowing of the major arteries in the neck that supply blood to the brain, most often caused by atherosclerotic plaque. When the narrowing exceeds fifty percent of the vessel diameter, the risk of ischemic cerebrovascular events rises sharply. But even in patients who have never experienced a transient ischemic attack or stroke, clinicians have long suspected that reduced or unstable perfusion may contribute to subtle cognitive impairment. Studying this silent phase is difficult precisely because patients feel well, and standard structural imaging often appears unremarkable. The Chinese team, led by Yiyun Zhang and corresponding author Lin Jiang, approached the problem with a pair of complementary analytical techniques that go beyond conventional, static pictures of brain function.

The first technique, dynamic functional connectivity (dFC), treats the brain not as a fixed wiring diagram but as a network whose links strengthen and weaken over seconds. The researchers used a sliding-window approach, chopping continuous resting-state fMRI recordings into short overlapping segments and computing a full connectivity matrix for each. Recurring patterns of connectivity, known as connectivity states, were then identified through clustering, allowing the team to derive temporal metrics such as how often the brain visits each state and how long it lingers there. The second technique, dynamic amplitude of low-frequency fluctuations (dALFF), quantifies the moment-to-moment intensity of spontaneous neural oscillations in each brain region. Crucially, the team computed dALFF not only in the conventional frequency band of 0.01 to 0.08 Hz but separately in two sub-bands: slow-5, spanning 0.01 to 0.027 Hz, and slow-4, spanning 0.027 to 0.073 Hz. This frequency-resolved strategy matters because different frequency bands are thought to reflect distinct physiological and neural processes, and vascular disease may affect them unequally.

Participants in the study were patients with unilateral moderate-to-severe carotid stenosis, graded at fifty percent or greater using criteria derived from the North American Symptomatic Carotid Endarterectomy Trial (NASCET), together with demographically matched healthy controls. All volunteers underwent comprehensive neuropsychological testing, including the mini-mental state examination (MMSE), the digit span test in its forward and backward forms, the Montreal Cognitive Assessment, and the Rey Auditory Verbal Learning Test, alongside the resting-state fMRI scanning session. Ethics approval was granted by the hospital’s ethics committee, and all participants provided written informed consent.

The results revealed a striking pattern. Across the conventional band and both sub-bands, ACS patients showed reduced dALFF compared with controls, meaning the amplitude of their spontaneous low-frequency brain activity was diminished. The affected regions were not random: they clustered within three major brain networks. The default mode network (DMN), which supports self-referential thought and memory consolidation; the frontoparietal network (FPN), the brain’s executive control system; and the sensorimotor network (SMN), which governs movement and bodily sensation, all showed frequency-dependent reductions. One region stood out for its consistency. The left triangular part of the inferior frontal gyrus, a hub for language and cognitive control, was abnormal in every frequency band examined, making it a potential marker of the earliest functional consequences of carotid narrowing.

The dynamic connectivity analysis painted an equally broad picture. ACS patients exhibited widespread alterations in connectivity involving frontal, parietal, and temporal cortical regions, as well as visual, limbic, and subcortical structures, including the right parahippocampal gyrus, the right insula, and the left caudate nucleus. These are not simply areas adjacent to the diseased artery; they span the entire brain, suggesting that chronic hemodynamic stress triggers a global reorganization of network dynamics rather than a localized deficit. The researchers interpret this as evidence that the brain compensates for compromised blood supply by shifting its patterns of coordination, a process that may carry a cognitive cost even when it succeeds in preserving basic function.

The relationship between these imaging abnormalities and cognition was more tentative. Several dALFF and dFC measures showed nominal associations with MMSE scores, digit span test performance, and forward and backward digit span results. These correlations, based on raw uncorrected p-values, hint at a link between altered brain dynamics and poorer attention, working memory, and global cognition. However, the authors are careful to note that none of these associations survived false discovery rate (FDR) correction, the statistical standard used to guard against false positives when many comparisons are made. The findings must therefore be considered preliminary. An additional sobering detail: after applying hemodynamic response function (HRF) correction, a procedure that accounts for the blurring influence of the blood-oxygenation signal on the underlying neural dynamics, no evidence of altered temporal state dynamics remained. Because carotid stenosis directly alters blood flow, disentangling neural change from vascular change is one of the central methodological challenges of the entire field, and the authors transparently report where that challenge limits interpretation.

Even so, the study’s conclusions carry weight for both researchers and clinicians. The demonstration that spontaneous local brain activity is altered in a frequency-dependent manner, while dynamic connectivity is reorganized across multiple networks, provides preliminary neuroimaging evidence for the pathological mechanisms that may underlie ACS-related cognitive decline. If brain dynamics begin to drift years before symptoms appear, then dynamic fMRI measures could eventually serve as early warning indicators, identifying which patients with silent carotid narrowing are most likely to benefit from aggressive management of vascular risk factors, or from revascularization procedures such as carotid endarterectomy or stenting. The work was supported by the National Natural Science Foundation of China and by grants from the Natural Science Foundation of Guizhou Province and the Zunyi Science and Technology Cooperation Project, and it emerges from a provincial innovation team dedicated to functional imaging and artificial intelligence applications.

The methodological toolkit itself represents a step forward for cerebrovascular neuroscience. Machine-learning classifiers mentioned in the study’s analytical framework, including linear and radial basis function support vector machines, random forests, and k-nearest neighbors models, evaluated with leave-one-out cross-validation and receiver operating characteristic analysis, reflect a growing ambition to translate dynamic imaging metrics into diagnostic tools. Whether dALFF reductions in the left inferior frontal gyrus or shifts in dFC state occupancy can ultimately classify patients with clinically useful accuracy will require larger, longitudinal cohorts. The present study’s sample, drawn from a single hospital and analyzed with uncorrected cognitive correlations, is best seen as a proof of concept rather than a definitive answer.

What makes the research resonate beyond the specialist literature is its implication for a remarkably common condition. Carotid atherosclerosis is widespread in aging populations, and many people carry significant narrowing without knowing it. The idea that the resting brain, scanned while a person simply lies still and thinks of nothing in particular, can betray the early consequences of that narrowing is both elegant and clinically provocative. It reframes asymptomatic carotid stenosis not as a dormant disease waiting to strike, but as an active process already imposing costs on brain function. Future work combining dynamic fMRI with direct perfusion measurements, longer follow-up, and stricter statistical correction will determine whether these network signatures can predict who will decline cognitively, and whether restoring blood flow can reverse them. For now, the Zunyi team’s results stand as an early, frequency-resolved portrait of a brain quietly adapting to a compromised blood supply, and a reminder that silence in the arteries is not always silence in the brain.

Employing resting-state functional magnetic resonance imaging (fMRI), the research team captured temporal fluctuations in brain activity across multiple interconnected regions. This approach allowed the delineation of both spatial configurations and temporal dynamics of functional networks, providing a more comprehensive view of brain organization in PTSD patients compared to traditional static connectivity analyses.

The study identifies distinct alterations in key functional networks, including the default mode network (DMN), salience network (SN), and central executive network (CEN), which are critical for cognitive and emotional regulation. Notably, PTSD subjects exhibited disrupted synchrony within and between these networks, reflecting impaired integration of internal and external information processing that may contribute to hallmark symptoms such as intrusive memories and hypervigilance.

A novel contribution of this work is the emphasis on spatiotemporal features, highlighting not only which brain regions are differently connected but also when and how these connections fluctuate over time. Such dynamic connectivity patterns provide a richer neural signature of PTSD, suggesting that the disorder involves instability in brain network coordination rather than mere static disruptions.

Furthermore, the study leverages sophisticated computational models and graph theoretical metrics to quantify network properties such as modularity, nodal efficiency, and temporal variability. These quantifiable signatures reveal that PTSD networks show reduced efficiency and heightened temporal volatility, indicating compromised information flow and network resilience.

By mapping these functional disruptions onto symptom severity scores, the authors demonstrate robust correlations, advancing the potential for neuroimaging-derived biomarkers that could assist in diagnosing PTSD or tracking treatment response. This opens avenues for precision medicine approaches tailored to neural dysfunction patterns rather than solely clinical presentation.

Overall, this research marks a significant leap in understanding the neurobiological underpinnings of PTSD through the lens of time-varying brain connectivity. It underscores the importance of considering the dynamic nature of brain function in psychiatric disorders, providing a scaffold for future explorations into targeted interventions that restore network stability.

As the field moves forward, integrating longitudinal studies and multimodal imaging may further unravel how trauma reshapes neural circuitry over time. The tools and findings presented here lay a foundation for developing novel diagnostics and therapeutics aimed at the intricate dance of brain networks disrupted in PTSD.

Subject of Research: Posttraumatic Stress Disorder (PTSD) and its neural network alterations

Article Title: Characteristic spatiotemporal features of large-scale functional network architecture in posttraumatic stress disorder

Article References:
Wu, J., Cai, Z., Hudson, L.J. et al. Characteristic spatiotemporal features of large-scale functional network architecture in posttraumatic stress disorder. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04216-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04216-x